Literature DB >> 24081761

An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health.

Dean E Schraufnagel1, Francesco Blasi, Monica Kraft, Mina Gaga, Patricia Finn, Klaus F Rabe.   

Abstract

Health disparities, defined as a significant difference in health between populations, are more common for diseases of the respiratory system than for those of other organ systems, because of the environmental influence on breathing and the variation of the environment among different segments of the population. The lowest social groups are up to 14 times more likely to have respiratory diseases than are the highest. Tobacco smoke, air pollution, environmental exposures, and occupational hazards affect the lungs more than other organs and occur disproportionately in ethnic minorities and those with lower socioeconomic status. Lack of access to quality healthcare contributes to disparities. The executive committees of the American Thoracic Society (ATS) and European Respiratory Society (ERS) established a writing committee to develop a policy on health disparities. The document was reviewed, edited, and approved by their full executive committees and boards of directors of the societies. This document expresses a policy to address health disparities by promoting scientific inquiry and training, disseminating medical information and best practices, and monitoring and advocating for public respiratory health. The ERS and the ATS have strong international commitments and work with leaders from governments, academia, and other organisational bodies to address and reduce avoidable health inequalities. Their training initiatives improve the function of healthcare systems and health equality. Both the ATS and the ERS support all aspects of this document, confer regularly, and act together when possible, but the activities to bring about change may vary because of the differences in the continents where the two organisations carry out most of their activities. The ATS and ERS pledge to frame their actions to reduce respiratory health disparities. The vision of the ATS and ERS is that all persons attain better and sustained respiratory health. They call on all their members and other societies to join in this commitment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081761     DOI: 10.1183/09031936.00062113

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD.

Authors:  Nurdan Köktürk; Alev Gürgün; Elif Şen; Ali Kocabaş; Mehmet Polatlı; Sibel Atış Naycı; Lütfi Çöplü; Emel Tellioğlu; Funda Elmas; Ertürk Erdinç
Journal:  Turk Thorac J       Date:  2017-04-01

2.  The pattern of respiratory disease morbidity and mortality in a tertiary hospital in southern-eastern Nigeria.

Authors:  Victor Aniedi Umoh; Akaninyene Otu; Henry Okpa; Emmanuel Effa
Journal:  Pulm Med       Date:  2013-12-17

3.  Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy.

Authors:  Sten Axelsson Fisk; Shai Mulinari; Maria Wemrell; George Leckie; Raquel Perez Vicente; Juan Merlo
Journal:  SSM Popul Health       Date:  2018-03-20

4.  Impact of patient characteristics and perceived barriers on referral to exercise rehabilitation among patients with pulmonary hypertension in the United States.

Authors:  Thomas M Cascino; Carmel Ashur; Caroline R Richardson; Elizabeth A Jackson; Vallerie V McLaughlin
Journal:  Pulm Circ       Date:  2020-12-08       Impact factor: 3.017

5.  Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis.

Authors:  Eric Moughames; Han Woo; Panagis Galiatsatos; Karina Romero-Rivero; Sarath Raju; Vickram Tejwani; Eric A Hoffman; Alejandro P Comellas; Victor E Ortega; Trisha Parekh; Jerry A Krishnan; Michael B Drummond; David Couper; Russell G Buhr; Robert Paine; Joel D Kaufman; Laura M Paulin; Nirupama Putcha; Nadia N Hansel
Journal:  BMC Pulm Med       Date:  2021-04-27       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.